Cargando…

PI3K/Akt signaling pathway triggers P2X7 receptor expression as a pro-survival factor of neuroblastoma cells under limiting growth conditions

The expression of purinergic P2X7 receptor (P2X7R) in neuroblastoma cells is associated to accelerated growth rate, angiogenesis, metastasis and poor prognosis. Noticeably, P2X7R allows the survival of neuroblastoma cells under restrictive conditions, including serum and glucose deprivation. Previou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gómez-Villafuertes, Rosa, García-Huerta, Paula, Díaz-Hernández, Juan Ignacio, Miras-Portugal, Mª Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685307/ https://www.ncbi.nlm.nih.gov/pubmed/26687764 http://dx.doi.org/10.1038/srep18417

Ejemplares similares

P2X7 Receptors Trigger ATP Exocytosis and Modify Secretory Vesicle Dynamics in Neuroblastoma Cells
por: Gutiérrez-Martín, Yolanda, et al.
Publicado: (2011)

The Specificity Protein Factor Sp1 Mediates Transcriptional Regulation of P2X7 Receptors in the Nervous System
por: García-Huerta, Paula, et al.
Publicado: (2012)

Age-Related Nuclear Translocation of P2X6 Subunit Modifies Splicing Activity Interacting with Splicing Factor 3A1
por: Díaz-Hernández, Juan Ignacio, et al.
Publicado: (2015)

Role of P2X7 and P2Y(2) receptors on α-secretase-dependent APP processing: Control of amyloid plaques formation “in vivo” by P2X7 receptor
por: Miras-Portugal, M. Teresa, et al.
Publicado: (2015)

Specific Temporal Distribution and Subcellular Localization of a Functional Vesicular Nucleotide Transporter (VNUT) in Cerebellar Granule Neurons
por: Menéndez-Méndez, Aida, et al.
Publicado: (2017)

Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma
por: Fonseca, Begoña, et al.
Publicado: (2017)

Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma
por: Westhoff, Mike-Andrew, et al.
Publicado: (2013)

Changes in melatonin receptor expression in a murine model of glaucoma
por: Martínez-Águila, Alejandro, et al.
Publicado: (2020)

P2X receptors as targets for the treatment of status epilepticus
por: Henshall, David C., et al.
Publicado: (2013)

Dual-Specificity Phosphatase Regulation in Neurons and Glial Cells
por: Pérez-Sen, Raquel, et al.
Publicado: (2019)

Physiopathological Role of the Vesicular Nucleotide Transporter (VNUT) in the Central Nervous System: Relevance of the Vesicular Nucleotide Release as a Potential Therapeutic Target
por: Miras-Portugal, María T., et al.
Publicado: (2019)

BCI, an inhibitor of the DUSP1 and DUSP6 dual specificity phosphatases, enhances P2X7 receptor expression in neuroblastoma cells
por: Benito-León, María, et al.
Publicado: (2022)

Alphavirus-induced hyperactivation of PI3K/AKT directs pro-viral metabolic changes
por: Mazzon, Michela, et al.
Publicado: (2018)

The vesicular nucleotide transporter (VNUT) is involved in the extracellular ATP effect on neuronal differentiation
por: Menéndez-Méndez, Aida, et al.
Publicado: (2015)

Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma
por: Moore, Nathan F., et al.
Publicado: (2014)

Polo-like kinase 4 mediates epithelial–mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway
por: Tian, Xiangdong, et al.
Publicado: (2018)

Apatinib induces apoptosis and autophagy via the PI3K/AKT/mTOR and MAPK/ERK signaling pathways in neuroblastoma
por: Yu, Xiying, et al.
Publicado: (2020)

The Neurotrophic Function of Glucagon-Like Peptide-1 Promotes Human Neuroblastoma Differentiation via the PI3K-AKT Axis
por: Yang, Jenq-Lin, et al.
Publicado: (2020)

Connectivity Map Analysis Indicates PI3K/Akt/mTOR Inhibitors as Potential Anti-Hypoxia Drugs in Neuroblastoma
por: Uva, Paolo, et al.
Publicado: (2021)

BCL11A Facilitates Cell Proliferation and Metastasis in Neuroblastoma via Regulating the PI3K/Akt Signaling Pathway
por: Jin, Qianya, et al.
Publicado: (2022)

IGF1R Contributes to Cell Proliferation in ALK-Mutated Neuroblastoma with Preference for Activating the PI3K-AKT Signaling Pathway
por: Guan, Jikui, et al.
Publicado: (2023)

Akt phosphorylates insulin receptor substrate to limit PI3K-mediated PIP3 synthesis
por: Kearney, Alison L, et al.
Publicado: (2021)

Role of PI3K in myocardial ischaemic preconditioning: mapping pro‐survival cascades at the trigger phase and at reperfusion
por: Rossello, Xavier, et al.
Publicado: (2017)

Modulation of telomere protection by the PI3K/AKT pathway
por: Méndez-Pertuz, Marinela, et al.
Publicado: (2017)

Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways
por: Subramonian, Divya, et al.
Publicado: (2020)

ISL1 promoted tumorigenesis and EMT via Aurora kinase A-induced activation of PI3K/AKT signaling pathway in neuroblastoma
por: Li, Mengzhen, et al.
Publicado: (2021)

BI-D1870 Induces Mitotic Dysfunction and Apoptosis in Neuroblastoma by Regulating the PI3K-Akt-mTORC1 Signal Axis
por: Jin, Liming, et al.
Publicado: (2023)

BPTF in bone marrow provides a potential progression biomarker regulated by TFAP4 through the PI3K/AKT pathway in neuroblastoma
por: Jiang, Chiyi, et al.
Publicado: (2023)

A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
por: Westhoff, Mike-Andrew, et al.
Publicado: (2014)

PI3K-AKT Pathway Modulation by Thymoquinone Limits Tumor Growth and Glycolytic Metabolism in Colorectal Cancer
por: Karim, Shahid, et al.
Publicado: (2022)

Hydrogen Sulfide Prevents Formation of Reactive Oxygen Species through PI3K/Akt Signaling and Limits Ventilator-Induced Lung Injury
por: Spassov, Sashko Georgiev, et al.
Publicado: (2017)

Getting the Akt Together: Guiding Intracellular Akt Activity by PI3K
por: Yudushkin, Ivan
Publicado: (2019)

HijAkt: The PI3K/Akt Pathway in Virus Replication and Pathogenesis
por: Dunn, Ewan F., et al.
Publicado: (2012)

Advanced glycation endproducts trigger autophagy in cadiomyocyte Via RAGE/PI3K/AKT/mTOR pathway
por: Hou, Xuwei, et al.
Publicado: (2014)

Celastrol inhibits the proliferation and migration of MCF-7 cells through the leptin-triggered PI3K/AKT pathway
por: Chen, Pingping, et al.
Publicado: (2022)

PI3K/AKT Pathway and Brain Malformations
por: Rice, Gavin B., et al.
Publicado: (2015)

PI3K and AKT: Unfaithful Partners in Cancer
por: Faes, Seraina, et al.
Publicado: (2015)

The PI3K/Akt Pathway in Meta-Inflammation
por: Acosta-Martinez, Maricedes, et al.
Publicado: (2022)

Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092
por: Yu, Yi, et al.
Publicado: (2015)

Programmed expression of pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in neuroblastoma cells
por: Islam, Mohammad Sazzadul, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d0u1qmg8pplnh0n97qkngslku2